Announcements Trials
Browse Landscape

Phase

Phase NA 3

Status

Recruiting 2Active not recruiting 1

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Gynecologic 1Genitourinary 1Gastrointestinal 1

Conditions

Ovarian Neoplasms 1Neoplasms 1Metastatic Hormone-Sensitive Prostate Cancer (mHSPC) 1Gastrointestinal Neoplasms 1

Interventions

Standard of Care 177Blood Specimen Collection 135Exercise 121Educational Status 113Methods 109Interviews as Topic 106Surveys and Questionnaires 105Practice Guidelines as Topic 105Early Intervention, Educational 93Magnetic Resonance Spectroscopy 80Specimen Handling 78Radiosurgery 69Radiotherapy 53Palliative Care 48Biopsy 40Patient Navigation 37Control Groups 34Resistance Training 33Therapeutics 32Surgical Procedures, Operative 31Drug Therapy 31Diet Therapy 30Behavior Therapy 29Counseling 28Proton Therapy 25Acupuncture Therapy 25Nutrition Assessment 24Exercise Test 24Magnetic Resonance Imaging 23Health Promotion 22

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase NA × Glutamyl Aminopeptidase × 1 year × Clear all
NCT05415527 2026-01-29

OPTIMOVA

Institut Bergonié

Phase NA Active not recruiting
25 enrolled
Gynecologic

Ovarian Neoplasms

NCT05649943 2025-09-03

APPROACH

Fondazione IRCCS Istituto Nazionale dei Tumori, Milano

Phase NA Recruiting
566 enrolled
Genitourinary

Metastatic Hormone-Sensitive Prostate Cancer (mHSPC)

NCT05441163 2025-06-24

ProActIF-01

Institut Curie

Phase NA Recruiting
50 enrolled
Gastrointestinal

Gastrointestinal Neoplasms, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡